Christopher Krueger - Dec 17, 2022 Form 4 Insider Report for Ventyx Biosciences, Inc. (VTYX)

Role: Chief Business Officer
Signature: /s/ Christopher Krueger
Stock symbol: VTYX
Transactions as of: Dec 17, 2022
Transactions value $: $0
Form type: 4
Date filed: 12/20/2022, 06:57 PM
Previous filing: Dec 15, 2022
Next filing: Dec 23, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VTYX	Common Stock	Options Exercise	$0	+10.5K	+3.8%	$0.00	286K	Dec 17, 2022	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VTYX	Restricted Stock Units	Options Exercise	$0	-10.5K	-25%	$0.00	31.4K	Dec 17, 2022	Common Stock	10.5K		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit ("RSU") represents a contingent right to receive one share of Ventyx Biosciences, Inc. common stock.
F2	Includes 2,773 shares of Common Stock acquired on May 16, 2022 and 379 shares of Common Stock acquired on November 15, 2022, through the Issuer's 2021 Employee Stock Purchase Plan.
F3	Subject to the reporting person's continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through such applicable vesting date, twenty five percent (25%) of the RSUs subject to the award shall vest on the one (1) year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the RSUs subject to the award shall vest on each of the next three Vesting Commencement Date anniversaries thereafter. "Vesting Commencement Date" shall mean December 17, 2021.